期刊文献+

有机质谱应用于抗体类药物结构解析的研究进展

Research Progress on Application of Organic Mass Spectrometry in Structural Analysis of Antibody Drugs
下载PDF
导出
摘要 抗体类药物因其靶向性,能够直接与目标特异结合,并且药物副作用小、毒性低,在临床上具有广阔的应用前景。质谱(MS)以其快速、高灵敏度和高分辨率成为抗体药物结构分析的重要手段,为药物的质量控制和安全性方面提供了强有力的技术支撑。该文针对快速发展的有机质谱技术在抗体类药物的氨基酸序列、高级结构以及修饰鉴定方面的应用进行了综述。 With their targeting abilities,small sid-effects and low toxicity,antibody drugs could be directly combined with target specific,and they have broad application prospects in clinical practice.With its rapidness,high sensitivity and resolution,mass spectrometry(MS) has become an important means to analyze the structure of antibody,which provides a strong technical support for quality control and safety of the drug. In this paper,the rapid application development of organic mass spectrometry in the consistency of the amino acid sequence of antibody class,advanced structure and post translational modification(PTMs) are reviewed.
出处 《分析测试学报》 CAS CSCD 北大核心 2017年第2期201-204,共4页 Journal of Instrumental Analysis
基金 新药创制重大专项(2014ZX09304311-001) 国家科技支撑计划(2015BAK45B01) 科技基础性工作(创新方法)专项(2012IM030300)
关键词 有机质谱 抗体 结构解析 综述 organic mass spectrometry antibody structural analysis review
  • 相关文献

参考文献2

二级参考文献21

  • 1Hongwei Xie, Asish Chakraborty, Joomi Ahn, et al. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and spectrometry technologies, mAbs, 2010,2(4) : 1-16.
  • 2Kallol Gupta, Mukesh Kumar, Padmanabhan Balaram. Disulfide bond assignments by mass spectrometry of native naturalpeptides: cysteine pairing in disulfide bonded conotoxins. Anal Chem, 2010, 82:8313-8319.
  • 3Doneanu C E, Xenopoulos A, Fadgen K, et al. Analysis of host- cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry. mAbs, 2012,4(1) : 24-44.
  • 4WALSH G. Biopharmaceutical benchmarks 2010 [ J ]. Nat Bio- technol,2010,28 (9) :917 - 924.
  • 5LAWRENCE S. Billion dollar babies-biotech drugs as blockbust- ers[ J]. Nat Biotechnol,2007,25 (4) :380 - 382.
  • 6ERICKSON BE. Untangling biosimilars [ J ]. Chem Errg News, 2010,88:25 - 27.
  • 7Guidance for industry, quality considerations in demonstrating biosimilarity to a reference protein product [ S/OL ]. (2012). ht- tp://www, fda. gov/downloads/Drugs/GuidanceComplianceRegu- latorylnformation/Guidances/UCM291134, pdf.
  • 8European Medicines Agency. Guideline on similar biological me- dicinal products containing biotechnology-derived proteins as an active substance : quality issues [ S/OL ]. http ://www. ema. eu- ropa. eu/docs/en _ GB/document _ library/Scientific _ guideline/ 2009/09/WC500003953. pdf(2011 ).
  • 9YU YQ,GILAR M,KASKA J,et al. A rapid sample preparation method for mass spectrometric characterization of N-linked gly- cans [ J ]. Rapid Commun Mass Spectrom,2005,19 ( 16 ) : 2331 - 2336.
  • 10AHN J, BONES J, YU Y, et al. Separation of 2-amlnobenzamide labeled glycans using hydrophilic interaction chromatography col- umns packed with 1.7 μm sorbent[ J]. J Chromatogr B Analyt Technol Biomed Life Sci ,2010,878 ( 3 - 4 ) :403 - 408.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部